2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
Tóm tắt
Từ khóa
Tài liệu tham khảo
Karkouti, 2004, The independent association of massive blood loss with mortality in cardiac surgery, Transfusion, 44, 1453, 10.1111/j.1537-2995.2004.04144.x
Ranucci, 2008, Surgical reexploration after cardiac operations: why a worse outcome?, Ann Thorac Surg, 86, 1557, 10.1016/j.athoracsur.2008.07.114
Paone, 2014, Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality, Ann Thorac Surg, 97, 87, 10.1016/j.athoracsur.2013.07.020
Frojd, 2016, Reexploration for bleeding and its association with mortality after cardiac surgery, Ann Thorac Surg, 102, 109, 10.1016/j.athoracsur.2016.01.006
Ndrepepa, 2012, Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention, Circulation, 125, 1424, 10.1161/CIRCULATIONAHA.111.060871
Mehran, 2011, Standardized bleeding definitions for cardiovascular clinical trials. A Consensus Report from the Bleeding Academic Research Consortium, Circulation, 123, 2736, 10.1161/CIRCULATIONAHA.110.009449
Alghamdi, 2006, Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs, Transfusion, 46, 1120, 10.1111/j.1537-2995.2006.00860.x
Ranucci, 2011, Patient blood management during cardiac surgery: do we have enough evidence for clinical practice?, J Thorac Cardiovasc Surg, 142, 249, 10.1016/j.jtcvs.2011.04.007
Ferraris, 2011, 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines, Ann Thorac Surg, 91, 944, 10.1016/j.athoracsur.2010.11.078
Goudie, 2015, Risk scores to facilitate preoperative prediction of transfusion and large volume blood transfusion associated with adult cardiac surgery, Br J Anaesth, 114, 757, 10.1093/bja/aeu483
Vuylsteke, 2011, The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding, Eur J Cardiothorac Surg, 39, 924, 10.1016/j.ejcts.2010.10.003
Karkouti, 2006, Prediction of massive blood transfusion in cardiac surgery, Can J Anesth, 53, 781, 10.1007/BF03022795
Al-Khabori, 2014, Transfusion indication predictive score: a proposed risk stratification score for perioperative red blood cell transfusion in cardiac surgery, Vox Sang, 107, 269, 10.1111/vox.12163
Biancari, 2017, Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score, Thromb Haemost, 117, 445, 10.1160/TH16-09-0721
Ranucci, 2009, Biagioli Predicting transfusions in cardiac surgery: the easier, the better: the Transfusion Risk and Clinical Knowledge score, Vox Sang, 96, 324, 10.1111/j.1423-0410.2009.01160.x
Kozek-Langenecker, 2017, Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016, Eur J Anaesthesiol, 34, 332, 10.1097/EJA.0000000000000630
2015, Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management, Anesthesiology, 122, 241, 10.1097/ALN.0000000000000463
Sousa-Uva, 2015, Methodology manual for European Association for Cardio Thoracic Surgery (EACTS) clinical guidelines, Eur J Cardiothorac Surg, 48, 809
Cantrill, 1996, The Delphi and nominal group techniques in health services research, Int J Pharm Pract, 4, 67, 10.1111/j.2042-7174.1996.tb00844.x
Malm, 2016, Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study, Br J Anaesth, 117, 309, 10.1093/bja/aew189
Mahla, 2016, Does platelet reactivity predict bleeding in patients needing urgent coronary artery bypass grafting during dual antiplatelet therapy?, Ann Thorac Surg, 102, 2010, 10.1016/j.athoracsur.2016.05.003
Blome, 2005, Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery, Thromb Haemost, 93, 1101, 10.1160/TH04-12-0799
Bosch, 2013, Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article, J Cardiothorac Surg, 8, 154, 10.1186/1749-8090-8-154
Karlsson, 2008, Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study, Transfusion, 48, 2152, 10.1111/j.1537-2995.2008.01827.x
Ranucci, 2015, Pre-operative fibrinogen supplementation in cardiac surgery patients: an evaluation of different trigger values, Acta Anaesthesiol Scand, 59, 427, 10.1111/aas.12469
Walden, 2014, Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations, Ann Thorac Surg, 97, 1199, 10.1016/j.athoracsur.2013.11.064
Gielen, 2014, The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis, Interact CardioVasc Thorac Surg, 18, 292, 10.1093/icvts/ivt506
Coakley, 2011, Assessment of thrombin generation measured before and after cardiopulmonary by-pass surgery and its association with postoperative bleeding, J Thromb Haemost, 9, 282, 10.1111/j.1538-7836.2010.04146.x
Reinhöfer, 2008, The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass, Blood Coagul Fibrinolysis, 19, 212, 10.1097/MBC.0b013e3282f3f9d4
Petricevic, 2013, Bleeding risk assessment using whole blood impedance aggregometry and rotational thromboelastometry in patients following cardiac surgery, J Thromb Thrombolysis, 36, 514, 10.1007/s11239-013-0868-1
Ranucci, 2011, Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines, Ann Thorac Surg, 91, 123, 10.1016/j.athoracsur.2010.09.022
Ranucci, 2014, Surgical, Clinical Outcome Research Group. Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery, Br J Anaesth, 113, 970, 10.1093/bja/aeu315
Mangano, 2002, Aspirin and mortality from coronary bypass surgery, N Engl J Med, 347, 1309, 10.1056/NEJMoa020798
Musleh, 2003, Does aspirin 6 h after coronary artery bypass grafting optimise graft patency?, Interact CardioVasc Thorac Surg, 2, 413, 10.1016/S1569-9293(03)00181-6
Smith, 2012, Mortality benefit with prasugrel in the TRITON-TIMI 38 coron- ary artery bypass grafting cohort: risk-adjusted retrospective data ana- lysis, J Am Coll Cardiol, 60, 388, 10.1016/j.jacc.2012.03.030
Hansson, 2016, Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study, Eur Heart J, 37, 189, 10.1093/eurheartj/ehv381
Gherli, 2016, Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting, JAMA Cardiol, 1, 921, 10.1001/jamacardio.2016.3028
Douketis, 2015, Perioperative bridging anticoagulation in patients with atrial fibril- lation, N Engl J Med, 373, 823, 10.1056/NEJMoa1501035
O’Donnell, 2007, Brief communication: preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin, Ann Intern Med, 146, 184, 10.7326/0003-4819-146-3-200702060-00007
Medalion, 2003, Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after coronary artery bypass surgery, J Thorac Cardiovasc Surg, 126, 1875, 10.1016/S0022-5223(03)01324-2
Landenhed, 2010, Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery, Scand Cardiovasc J, 44, 100, 10.3109/14017430903388334
Spyropoulos, 2006, Clinical outcomes with unfractionated heparin or low- molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry, J Thromb Haemost, 4, 1246, 10.1111/j.1538-7836.2006.01908.x
Jones, 2002, Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports, Circulation, 106, I19
Spyropoulos, 2008, Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry), Am J Cardiol, 102, 883, 10.1016/j.amjcard.2008.05.042
Douketis, 2004, Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen, Arch Intern Med, 164, 1319, 10.1001/archinte.164.12.1319
2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, Br Med J, 324, 71, 10.1136/bmj.324.7329.71
Hastings, 2015, Aspirin and coronary artery surgery: a systematic review and meta-analysis, Br J Anaesth, 115, 376, 10.1093/bja/aev164
Sun, 2008, The effect of pre-operative aspirin on bleeding, transfusion, myo- cardial infarction, and mortality in coronary artery bypass surgery: a sys- tematic review of randomized and observational studies, Eur Heart J, 29, 1057, 10.1093/eurheartj/ehn104
Myles, 2016, Stopping vs. continuing aspirin before coronary artery surgery, N Engl J Med, 374, 728, 10.1056/NEJMoa1507688
Deja, 2012, Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo-controlled, randomized trial, J Thorac Cardiovasc Surg, 144, 204, 10.1016/j.jtcvs.2012.04.004
Morawski, 2005, Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism, J Thorac Cardiovasc Surg, 130, 791, 10.1016/j.jtcvs.2005.02.041
Hansson, 2014, Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor, Br J Anaesth, 112, 570, 10.1093/bja/aet339
Martin, 2016, The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: an in-vitro study, Eur J Anaesthesiol, 33, 361, 10.1097/EJA.0000000000000348
Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syn- dromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746
Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syn- dromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327
Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute cor- onary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482
Becker, 2011, Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial, Eur Heart J, 32, 2933, 10.1093/eurheartj/ehr422
Levine, 2016, 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 68, 1082, 10.1016/j.jacc.2016.03.513
Qamar, 2016, Current status of data on cangrelor, Pharmacol Ther, 159, 102, 10.1016/j.pharmthera.2016.01.004
Fox, 2004, Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coron- ary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial, Circulation, 110, 1202, 10.1161/01.CIR.0000140675.85342.1B
Held, 2011, Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial, J Am Coll Cardiol, 57, 672, 10.1016/j.jacc.2010.10.029
Tomsic, 2016, Coronary artery bypass grafting-related bleeding complications in pa- tients treated with dual antiplatelet treatment, Eur J Cardiothorac Surg, 50, 849, 10.1093/ejcts/ezw149
Pickard, 2008, Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting, Pharmacotherapy, 28, 376, 10.1592/phco.28.3.376
Purkayastha, 2006, Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis, Heart, 92, 531, 10.1136/hrt.2004.058396
Ferraris, 2012, 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations, Ann Thorac Surg, 94, 1761, 10.1016/j.athoracsur.2012.07.086
Wallentin, 2009, P2Y(12) inhibitors: differences in properties and mechan- isms of action and potential consequences for clinical use, Eur Heart J, 30, 1964, 10.1093/eurheartj/ehp296
Gurbel, 2009, Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study, Circulation, 120, 2577, 10.1161/CIRCULATIONAHA.109.912550
Storey, 2011, Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses, J Thromb Haemost, 9, 1730, 10.1111/j.1538-7836.2011.04419.x
Kwak, 2010, Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery, J Am Coll Cardiol, 56, 1994, 10.1016/j.jacc.2010.03.108
Savonitto, 2010, Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel, Br J Anaesth, 104, 285, 10.1093/bja/aep373
Patrono, 2004, Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 234S, 10.1378/chest.126.3_suppl.234S
Dyke, 2007, Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass, J Cardiovasc Pharmacol Ther, 12, 54, 10.1177/1074248406299068
De Carlo, 2008, Emergency coronary artery bypass grafting in patients with acute myo- cardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors, Int J Cardiol, 123, 229, 10.1016/j.ijcard.2007.02.005
Boeken, 2008, CABG-procedures in patients with pretreatment with the GPIIb/IIIa-receptor antagonist tiro- fiban (Aggrastat): modification of perioperative management?, Int J Cardiol, 127, 257, 10.1016/j.ijcard.2007.02.062
Kincaid, 2003, Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting, Ann Thorac Surg, 76, 124, 10.1016/S0003-4975(03)00190-5
Ashikhmina, 2014, Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest, Ann Thorac Surg, 98, 2215, 10.1016/j.athoracsur.2014.01.077
Stein, 2014, Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence: case report with literature review, Acta Anaesthesiol Scand, 58, 630, 10.1111/aas.12303
Crapelli, 2016, A case of fatal bleeding following emergency surgery on an ascending aorta intramural hematoma in a patient taking dabigatran, J Cardiothorac Vasc Anesth, 30, 1027, 10.1053/j.jvca.2015.10.017
Weltert, 2015, A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial, Transfusion, 55, 1644, 10.1111/trf.13027
Weltert, 2010, Preoperative very short-term, high-dose erythropoietin adminis- tration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study, J Thorac Cardiovasc Surg, 139, 621, 10.1016/j.jtcvs.2009.10.012
Yoo, 2011, Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery, Anesthesiology, 115, 929, 10.1097/ALN.0b013e318232004b
Hogan, 2015, The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery, Eur J Cardiothorac Surg, 47, 218, 10.1093/ejcts/ezu200
Matsuda, 2013, Associations between preoperative anemia and outcomes after off-pump coronary artery bypass grafting, Ann Thorac Surg, 95, 854, 10.1016/j.athoracsur.2012.10.005
Zhang, 2013, Preoperative anemia does not increase the risks of early surgical revascularization after myocardial infarction, Ann Thorac Surg, 95, 542, 10.1016/j.athoracsur.2012.07.011
Cutrell, 2016, Risk factors for deep sternal wound infection after cardiac surgery: influence of red blood cell transfusions and chronic infection, Am J Infect Control, 44, 1302, 10.1016/j.ajic.2016.03.027
Engoren, 2014, The independent effects of anemia and transfusion on mortality after coronary artery bypass, Ann Thorac Surg, 97, 514, 10.1016/j.athoracsur.2013.09.019
von Heymann, 2016, Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?, J Thorac Cardiovasc Surg, 152, 1412, 10.1016/j.jtcvs.2016.06.010
Garrido-Martin, 2012, The effect of intraven- ous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial, Interact CardioVasc Thorac Surg, 15, 1013, 10.1093/icvts/ivs344
Kulier, 2007, Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery, Circulation, 116, 471, 10.1161/CIRCULATIONAHA.106.653501
Karkouti, 2008, Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study, Circulation, 117, 478, 10.1161/CIRCULATIONAHA.107.718353
Kozek-Langenecker, 2013, Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology, Eur J Anaesthesiol, 30, 270, 10.1097/EJA.0b013e32835f4d5b
Menkis, 2012, Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011, Innovations (Phila), 7, 229, 10.1097/IMI.0b013e3182747699
Karkouti, 2012, Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial, Anesthesiology, 116, 613, 10.1097/ALN.0b013e3182475e39
Deppe, 2016, Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with meta-analysis of over 16, 900 patients investigated in randomized controlled trialsdagger, Eur J Cardiothorac Surg, 49, 1031, 10.1093/ejcts/ezv268
Puskas, 2015, ISMICS consensus conference and statements of randomized controlled trials of off-pump versus conventional coronary artery bypass surgery, Innovations (Phila), 10, 219, 10.1097/IMI.0000000000000184
Anastasiadis, 2013, Use of minimal extracorporeal circulation improves outcome after heart surgery; a systematic review and meta-analysis of randomized controlled trials, Int J Cardiol, 164, 158, 10.1016/j.ijcard.2012.01.020
Harling, 2011, Do miniaturized extracorporeal circuits confer significant clinical benefit without compromising safety? A meta-analysis of randomized controlled trials, ASAIO J, 57, 141, 10.1097/MAT.0b013e318209d63b
Sundermann, 2014, Mitral valve surgery: right lateral minithoracotomy or sternotomy? A systematic review and meta-analysis, J Thorac Cardiovasc Surg, 148, 1989, 10.1016/j.jtcvs.2014.01.046
Falk, 2011, Minimally invasive versus open mitral valve surgery: a consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010, Innovations (Phila), 6, 66, 10.1097/IMI.0b013e318216be5c
Phan, 2014, A meta-analysis of minimally invasive versus conventional sternotomy for aortic valve replacement, Ann Thorac Surg, 98, 1499, 10.1016/j.athoracsur.2014.05.060
Tavilla, 2015, Multicentre randomized clinical trial to investigate the costeffectiveness of an allogeneic single-donor fibrin sealant after coronary artery bypass grafting (FIBER Study), Br J Surg, 102, 1338, 10.1002/bjs.9877
Lamy, 2012, Off-pump or on-pump coronary-artery bypass grafting at 30 days, N Engl J Med, 366, 1489, 10.1056/NEJMoa1200388
Diegeler, 2013, Off-pump versus on-pump coronary-artery bypass grafting in elderly patients, N Engl J Med, 368, 1189, 10.1056/NEJMoa1211666
Anastasiadis, 2016, Use of minimal invasive extracorporeal circulation in cardiac surgery: principles, definitions and potential benefits. A position paper from the Minimal invasive Extra-Corporeal Technologies international Society (MiECTiS), Interact CardioVasc Thorac Surg, 22, 647, 10.1093/icvts/ivv380
Carless, 2003, Fibrin sealant use for minimizing peri-operative allogeneic blood transfusion, Cochrane Database Syst Rev, 2
Abrishami, 2009, Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis, Can J Anaesth, 56, 202, 10.1007/s12630-008-9038-x
Ker, 2013, Topical application of tranexamic acid for the reduction of bleeding, Cochrane Database Syst Rev, 7, D010562
Gurian, 2014, A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass, Clin Appl Thromb Hemost, 20, 615, 10.1177/1076029613476338
Casalino, 2008, Reduced transfusion requirements with a closed cardiopulmonary bypass system, J Cardiovasc Surg (Torino), 49, 363
Nakahira, 2011, Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery, J Thorac Cardiovasc Surg, 141, 1289, 10.1016/j.jtcvs.2010.07.024
Ranucci, 2009, A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome, Ann Thorac Surg, 87, 1311, 10.1016/j.athoracsur.2008.09.076
Landis, 2014, Attenuating the systemic inflammatory response to adult cardiopulmonary bypass: a critical review of the evidence base, J Extra Corpor Technol, 46, 197, 10.1051/ject/201446197
Mahmood, 2012, Is a fully heparin-bonded car-diopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?, Interact CardioVasc Thorac Surg, 14, 406, 10.1093/icvts/ivr124
Carless, 2010, Cell salvage for minimising perioperative allogeneic blood transfusion, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD001888.pub3
Vermeijden, 2016, Additional postoperative cell salvage of shed mediastinal blood in cardiac surgery does not reduce allogeneic blood transfusions: a cohort study, Perfusion, 31, 384, 10.1177/0267659115613428
Vonk, 2013, Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study, Transfusion, 53, 2782, 10.1111/trf.12126
Zakkar, 2015, Modified ultrafiltration in adult patients undergoing cardiac surgery, Interact CardioVasc Thorac Surg, 20, 415, 10.1093/icvts/ivu388
Boodhwani, 2006, Ultrafiltration reduces blood transfusions following cardiac surgery: a meta-analysis, Eur J Cardiothorac Surg, 30, 892, 10.1016/j.ejcts.2006.09.014
Luciani, 2001, Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial, Circulation, 104, I253, 10.1161/hc37t1.094931
Sun, 2013, Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis, Perfusion, 28, 238, 10.1177/0267659112474861
Saczkowski, 2009, Retrograde autologous priming and allogeneic blood transfusions: a meta-analysis, Interact CardioVasc Thorac Surg, 8, 373, 10.1510/icvts.2008.195354
Vandewiele, 2013, The effect of retrograde autologous priming volume on haemodilution and transfusion requirements during cardiac surgery, Interact CardioVasc Thorac Surg, 16, 778, 10.1093/icvts/ivt085
Ranucci, 2015, Moderate-degree acidosis is an independent determinant of postoperative bleeding in cardiac surgery, Minerva Anestesiol, 81, 885
Lee, 2014, The influence of hypothermia on transfusion requirement in patients who received clopidogrel in proximity to off-pump coronary bypass surgery, Yonsei Med J, 55, 224, 10.3349/ymj.2014.55.1.224
El-Sabbagh, 2013, Effect of air exposure and suction on blood cell activation and hemolysis in an in vitro cardiotomy suction model, ASAIO J, 59, 474, 10.1097/MAT.0b013e31829f0e6e
Murphy, 2009, Optimal perfusion during car-diopulmonary bypass: an evidence-based approach, Anesth Analg, 108, 1394, 10.1213/ane.0b013e3181875e2e
Lindholm, 2004, A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients, Ann Thorac Surg, 78, 2131, 10.1016/j.athoracsur.2004.06.011
Mirow, 2008, Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery, J Cardiovasc Surg (Torino), 49, 277
Paparella, 2012, A biocompatible cardiopulmonary bypass strategy to reduce hemostatic and inflammatory alterations: a randomized controlled trial, J Cardiothorac Vasc Anesth, 26, 557, 10.1053/j.jvca.2012.04.010
Lorusso, 2008, Effects of phosphorylcholine coating on extracorporeal circulation management and postoperative outcome: a double-blind randomized study, Interact CardioVasc Thorac Surg, 8, 7, 10.1510/icvts.2008.176479
Marguerite, 2012, Impact of a phosphorylcholine-coated cardiac bypass circuit on blood loss and platelet function: a prospective, randomized study, J Extra Corpor Technol, 44, 5, 10.1051/ject/201244005
Hosoyama, 2016, Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparincoated circuit during aortic arch surgery, J Artif Organs, 19, 233, 10.1007/s10047-016-0887-8
Thiara, 2011, Biocompatibility and pathways of initial complement pathway activation with Phisioand PMEA-coated cardiopulmonary bypass circuits during open-heart surgery, Perfusion, 26, 107, 10.1177/0267659110392438
Carless, 2006, Cell salvage for minimising perioperative allogeneic blood transfusion, Cochrane Database Syst Rev, 4
Wang, 2009, The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials, Anesth Analg, 109, 320, 10.1213/ane.0b013e3181aa084c
Weltert, 2013, Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intraand postoperative blood salvage strategy: results of a randomized comparison, Transfusion, 53, 790, 10.1111/j.1537-2995.2012.03836.x
Engels, 2016, Intraoperative cell salvage during cardiac surgery is associated with reduced postoperative lung injury, Interact CardioVasc Thorac Surg, 22, 298, 10.1093/icvts/ivv355
Gabel, 2013, Cell salvage of cardiotomy suction blood improves the balance between proand antiinflammatory cytokines after cardiac surgery, Eur J Cardiothorac Surg, 44, 506, 10.1093/ejcts/ezt019
Damgaard, 2010, Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial, Ann Thorac Surg, 89, 1511, 10.1016/j.athoracsur.2010.02.003
Jewell, 2003, A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery, Eur J Cardiothorac Surg, 23, 633, 10.1016/S1010-7940(02)00834-5
Rubens, 2007, The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function, Circulation, 116, I89, 10.1161/CIRCULATIONAHA.106.678987
Al-Khabori, 2015, Discriminatory power of the intraoperative cell salvage use in the prediction of platelet and plasma transfusion in patients undergoing cardiac surgery, Transfus Apher Sci, 53, 208, 10.1016/j.transci.2015.03.019
Liumbruno, 2011, Unwashed shed blood: should we transfuse it?, Blood Transfus, 9, 241
Hou, 2009, Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion in small adults: a prospective, randomized trial, Eur J Anaesthesiol, 26, 1061, 10.1097/EJA.0b013e32833244c8
Nathan, 2004, Safety of deliberate intraoperative and postoperative hypothermia for patients undergoing coronary artery surgery: a randomized trial, J Thorac Cardiovasc Surg, 127, 1270, 10.1016/j.jtcvs.2003.07.018
Vonk, 2014, Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery, J Cardiothorac Vasc Anesth, 28, 235, 10.1053/j.jvca.2013.09.007
Noui, 2012, Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS device, Perfusion, 27, 214, 10.1177/0267659112436632
Hoenicka, 2015, Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management, J Thromb Haemost, 13, 1196, 10.1111/jth.12999
Wang, 2013, Blood loss after cardiopulmonary bypass, standard vs titrated protamine: a meta-analysis, Neth J Med, 71, 123
Meesters, 2016, Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial, Thromb Haemost, 116, 251, 10.1160/TH16-02-0117
Avidan, 2005, A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass, Anesthesiology, 102, 276, 10.1097/00000542-200502000-00007
Avidan, 2005, Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass, J Thorac Cardiovasc Surg, 130, 107, 10.1016/j.jtcvs.2004.10.045
Finley, 2013, Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass, Anesth Analg, 116, 1210, 10.1213/ANE.0b013e31827e4e62
Hofmann, 2013, Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy, Perfusion, 28, 412, 10.1177/0267659113483800
Aziz, 2006, Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery?, Interact Cardio Vasc Thorac Surg, 5, 469, 10.1510/icvts.2006.133785
Pappalardo, 2006, Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration, Perfusion, 21, 285, 10.1177/0267659106074770
Avidan, 2004, Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery, Br J Anaesth, 92, 178, 10.1093/bja/aeh037
Slight, 2008, A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass, J Cardiothorac Vasc Anesth, 22, 47, 10.1053/j.jvca.2007.07.011
Radulovic, 2015, Heparin and protamine titration does not improve haemostasis after cardiac surgery: a prospective randomized study, PLoS One, 10, e0130271, 10.1371/journal.pone.0130271
Teoh, 2004, Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?, J Thorac Cardiovasc Surg, 128, 211, 10.1016/j.jtcvs.2003.12.023
Koster, 2014, Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study, Clin Appl Thromb Hemost, 20, 290, 10.1177/1076029613484085
Slaughter, 2001, Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation, Blood Coagul Fibrinolysis, 12, 25, 10.1097/00001721-200101000-00004
Ranucci, 2013, Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial, J Thorac Cardiovasc Surg, 145, 1393, 10.1016/j.jtcvs.2012.09.061
Linkins, 2012, Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e495S, 10.1378/chest.11-2303
Warkentin, 2014, Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin, Blood, 123, 2485, 10.1182/blood-2013-10-533083
Lo, 2007, What is the potential for overdiagnosis of heparin-induced thrombocytopenia?, Am J Hematol, 82, 1037, 10.1002/ajh.21032
Smedira, 2006, Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study, J Thorac Cardiovasc Surg, 131, 686, 10.1016/j.jtcvs.2005.10.049
Dyke, 2007, Off-pump coronary artery bypass with bivalirudin for patients with heparininduced thrombocytopenia or antiplatelet factor four/heparin antibodies, Ann Thorac Surg, 84, 836, 10.1016/j.athoracsur.2007.04.007
Dyke, 2006, A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study, J Thorac Cardiovasc Surg, 131, 533, 10.1016/j.jtcvs.2005.09.057
Koster, 2007, Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial, Ann Thorac Surg, 83, 572, 10.1016/j.athoracsur.2006.09.038
Palatianos, 2015, Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): an 11-year experience, Am J Hematol, 90, 608, 10.1002/ajh.24017
Koster, 2001, One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II, J Thorac Cardiovasc Surg, 122, 1254, 10.1067/mtc.2001.118271
Welsby, 2010, Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia, Anesth Analg, 110, 30, 10.1213/ANE.0b013e3181c3c1cd
Warkentin, 2015, Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities, Blood, 125, 195, 10.1182/blood-2014-07-590844
Tran, 2014, Effects of a multimodality blood conservation schema toward improvement of intraoperative hemoglobin levels and off-pump transfusions in coronary artery bypass graft surgery, Transfusion, 54, 2769, 10.1111/trf.12745
Vretzakis, 2010, Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial, J Cardiothorac Surg, 5, 7, 10.1186/1749-8090-5-7
Ranucci, 2010, Hematocrit on cardiopulmonary bypass and outcome after coronary surgery in nontransfused patients, Ann Thorac Surg, 89, 11, 10.1016/j.athoracsur.2009.07.078
Martin, 2010, Efficiency and safety of preoperative autologous blood donation in cardiac surgery: a matched-pair analysis in 432 patients, Eur J Cardiothorac Surg, 37, 1396, 10.1016/j.ejcts.2009.11.053
Dietrich, 2005, Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness, J Cardiothorac Vasc Anesth, 19, 589, 10.1053/j.jvca.2005.04.017
Carless, 2004, Autologous transfusion techniques: a systematic review of their efficacy, Transfus Med, 14, 123, 10.1111/j.0958-7578.2004.0489.x
Barile, 2017, Acute normovolemic hemodilution reduces allogeneic red blood cell transfusion in cardiac surgery: a systematic review and metaanalysis of randomized trials, Anesth Analg, 124, 743, 10.1213/ANE.0000000000001609
Osawa, 2016, Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery: a randomized clinical trial and systematic review, Crit Care Med, 44, 724, 10.1097/CCM.0000000000001479
Damen, 2016, Pressure-dependent changes in haematocrit and plasma volume during anaesthesia, a randomised clinical trial, Acta Anaesthesiol Scand, 60, 560, 10.1111/aas.12687
Goepfert, 2013, Individually optimized hemodynamic therapy reduces complications and length of stay in the intensive care unit: a prospective, randomized controlled trial, Anesthesiology, 119, 824, 10.1097/ALN.0b013e31829bd770
Bethlehem, 2014, Influence of two colloidal extracorporeal primes on coagulation of cardiac surgical patients: a prospectively randomized open-label pilot trial, J Extra Corpor Technol, 46, 293, 10.1051/ject/201446293
Cho, 2014, Effect of 6% hydroxyethyl starch 130/0.4 as a priming solution on coagulation and inflammation following complex heart surgery, Yonsei Med J, 55, 625, 10.3349/ymj.2014.55.3.625
Kuitunen, 2004, Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery, Anesth Analg, 98, 291, 10.1213/01.ANE.0000096006.60716.F6
Schramko, 2015, The use of balanced HES 130/0.42 during complex cardiac surgery; effect on blood coagulation and fluid balance: a randomized controlled trial, Perfusion, 30, 224, 10.1177/0267659114540022
Kamra, 2013, Human albumin in extracorporeal prime: effect on platelet function and bleeding, Perfusion, 28, 536, 10.1177/0267659113492836
Van der Linden, 2004, 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients, Can J Anesth, 51, 236, 10.1007/BF03019102
Kasper, 2003, Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses, Anesthesiology, 99, 42, 10.1097/00000542-200307000-00010
Gurbuz, 2013, Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study, J Cardiothorac Surg, 8, 71, 10.1186/1749-8090-8-71
Min, 2009, Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?, Asian Cardiovasc Thorac Ann, 17, 368, 10.1177/0218492309338101
Vanhoonacker, 2009, Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG, Acta Anaesthesiol Belg, 60, 91
Hecht-Dolnik, 2009, Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial, J Thorac Cardiovasc Surg, 138, 703, 10.1016/j.jtcvs.2009.02.035
Van der Linden, 2005, Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs, Anesth Analg, 101, 629, 10.1213/01.ANE.0000175216.53374.27
Skhirtladze, 2014, Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer’s lactate on blood loss and coagulation after cardiac surgery, Br J Anaesth, 112, 255, 10.1093/bja/aet348
DeFoe, 2001, Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group, Ann Thorac Surg, 71, 769, 10.1016/S0003-4975(00)02393-6
Lewis, 2005, Autologous blood transfusion in elective cardiac valve operations, J Card Surg, 20, 513, 10.1111/j.1540-8191.2005.00137.x
Myles, 2017, Tranexamic acid in patients undergoing coronary-artery surgery, N Engl J Med, 376, 136, 10.1056/NEJMoa1606424
Henry, 2011, Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD001886.pub3
Sedrakyan, 2004, Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials, J Thorac Cardiovasc Surg, 128, 442, 10.1016/j.jtcvs.2004.03.041
Desborough, 2015, Fresh frozen plasma for cardiovascular surgery, Cochrane Database Syst Rev, 7
Stanworth, 2004, Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials, Br J Haematol, 126, 139, 10.1111/j.1365-2141.2004.04973.x
Casbard, 2004, The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review, Anaesthesia, 59, 550, 10.1111/j.1365-2044.2004.03711.x
Demeyere, 2010, Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study, Vox Sang, 99, 251, 10.1111/j.1423-0410.2010.01339.x
Johansen, 2015, Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients, Cochrane Database Syst Rev, 7
Godje, 2006, Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation, Thorac Cardiovasc Surg, 54, 26, 10.1055/s-2005-872853
Karkouti, 2013, Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial, J Thorac Cardiovasc Surg, 146, 927, 10.1016/j.jtcvs.2013.04.044
Bilecen, 2017, Effect of fibrinogen concentrate on intraoperative blood loss among patients with intraoperative bleeding during high-risk cardiac surgery: a randomized clinical trial, JAMA, 317, 738, 10.1001/jama.2016.21037
Wikkelso, 2013, Fibrinogen concentrate in bleeding patients, Cochrane Database Syst Rev, 8
Fassl, 2013, Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: effect of thromboelastometry-guided transfusion management, J Cardiothorac Vasc Anesth, 27, 1181, 10.1053/j.jvca.2013.02.009
Bilecen, 2013, Fibrinogen concentrate therapy in complex cardiac surgery, J Cardiothorac Vasc Anesth, 27, 12, 10.1053/j.jvca.2012.06.006
Ortmann, 2015, An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery, Anesth Analg, 121, 26, 10.1213/ANE.0000000000000689
Bolliger, 2010, Pathophysiology and treatment of coagulopathyin massive hemorrhage and hemodilution, Anesthesiology, 113, 1205, 10.1097/ALN.0b013e3181f22b5a
Bignami, 2016, Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial, Acta Anaesthesiol Scand, 60, 892, 10.1111/aas.12740
Wademan, 2014, Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults, Interact CardioVasc Thorac Surg, 18, 360, 10.1093/icvts/ivt491
Gill, 2009, Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery, Circulation, 120, 21, 10.1161/CIRCULATIONAHA.108.834275
Simpson, 2012, Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia, Cochrane Database Syst Rev, 3
Adler Ma, 2011, Tranexamic acid is associated with less blood transfusion in offpump coronary artery bypass graft surgery: a systematic review and meta-analysis, J Cardiothorac Vasc Anesth, 25, 26, 10.1053/j.jvca.2010.08.012
Ker, 2012, Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis, Br Med J, 344, e3054, 10.1136/bmj.e3054
Sharma, 2014, The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients, Anaesthesia, 69, 124, 10.1111/anae.12516
Koster, 2013, Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome, Br J Anaesth, 110, 34, 10.1093/bja/aes310
Karkouti, 2006, A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery, Transfusion, 46, 327, 10.1111/j.1537-2995.2006.00724.x
Mangano, 2006, The risk associated with aprotinin in cardiac surgery, N Engl J Med, 354, 353, 10.1056/NEJMoa051379
Walkden, 2013, Increased periopera-tive mortality following aprotinin withdrawal: a real-world analysis of blood management strategies in adult cardiac surgery, Intensive Care Med, 39, 1808, 10.1007/s00134-013-3020-y
Howell, 2013, Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin, J Thorac Cardiovasc Surg, 145, 234, 10.1016/j.jtcvs.2012.07.018
Pagano, 2008, Bleeding in cardiac surgery: the use of aprotinin does not affect survival, J Thorac Cardiovasc Surg, 135, 495, 10.1016/j.jtcvs.2007.11.045
Fergusson, 2008, A comparison of aprotinin and lysine analogues in high-risk cardiac surgery, N Engl J Med, 358, 2319, 10.1056/NEJMoa0802395
McMullan, 2013, III. Aprotinin and cardiac surgery: a sorry tale of evidence misused, Br J Anaesth, 110, 675, 10.1093/bja/aet008
Canada H. Health Canada Decision on Trasylol (Aprotinin) (21 September 2011, date last accessed).
Agency E. European Medicines Agency Recommends Lifting Suspension of Aprotinin; Review Finds That Benefits of All Antifibrinolytic Medicines Outweigh Risks in Restricted Range of Indications (17 February 2012, date last accessed).
Yang, 2012, Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials, Transfusion, 52, 1673, 10.1111/j.1537-2995.2011.03515.x
Karkouti, 2010, The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study, Anesth Analg, 110, 1533, 10.1213/ANE.0b013e3181db7991
Ternstrom, 2010, Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study, Thromb Res, 126, e128, 10.1016/j.thromres.2010.05.028
Theusinger, 2010, In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM), Thromb Haemost, 104, 385, 10.1160/TH09-12-0858
Karkouti, 2013, The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study, Anesth Analg, 117, 14, 10.1213/ANE.0b013e318292efa4
Levy, 2009, Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer. A preliminary report, Thromb Haemost, 102, 765, 10.1160/TH08-12-0826
Hiippala, 1995, Hemostatic factors and replace-ment of major blood loss with plasma-poor red cell concentrates, Anesth Analg, 81, 360
Bolliger, 2009, Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery?, Transfusion, 49, 2006, 10.1111/j.1537-2995.2009.02295.x
Jeppsson, 2016, Preoperative supplementation with fibrinogen concentrate in cardiac surgery: a randomized controlled study, Br J Anaesth, 116, 208, 10.1093/bja/aev367
Rahe-Meyer, 2013, Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebocontrolled trial, Anesthesiology, 118, 40, 10.1097/ALN.0b013e3182715d4d
Ranucci, 2015, Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery, J Am Heart Assoc, 4, 10.1161/JAHA.115.002066
Rahe-Meyer, 2016, Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy, Br J Anaesth, 117, 41, 10.1093/bja/aew169
Ranucci, 2016, Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST), Br J Anaesth, 116, 618, 10.1093/bja/aev539
Fassl, 2015, Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery, Br J Anaesth, 114, 225, 10.1093/bja/aeu364
Ghadimi, 2016, Prothrombin complex concentrates for bleeding in the perioperative setting, Anesth Analg, 122, 1287, 10.1213/ANE.0000000000001188
Arnekian, 2012, Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery, Interact CardioVasc Thorac Surg, 15, 382, 10.1093/icvts/ivs224
Cappabianca, 2016, Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery, Crit Care, 20, 5, 10.1186/s13054-015-1172-6
Carless, 2004, Desmopressin for minimising perioperative allogeneic blood transfusion, Cochrane Database Syst Rev, 1
Crescenzi, 2008, Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials, Anesthesiology, 109, 1063, 10.1097/ALN.0b013e31818db18b
Desborough, 2017, Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials, J Thromb Haemost, 15, 263, 10.1111/jth.13576
Steiner, 2015, Effects of red-cell storage duration on patients undergoing cardiac surgery, N Engl J Med, 372, 1419, 10.1056/NEJMoa1414219
Lacroix, 2015, Age of transfused blood in critically ill adults, N Engl J Med, 372, 1410, 10.1056/NEJMoa1500704
Dzieciatkowska, 2013, Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction, Vox Sang, 105, 210, 10.1111/vox.12042
Membe, 2011, Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis [Internet].
Deppe, 2016, Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients, J Surg Res, 203, 424, 10.1016/j.jss.2016.03.008
Serraino, 2017, Routine use of viscoelastic blood tests for diag-nosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis, Br J Anaesth, 118, 823, 10.1093/bja/aex100
Karkouti, 2016, Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial, Circulation, 134, 1152, 10.1161/CIRCULATIONAHA.116.023956
Murphy, 2015, Liberal or restrictive transfusion after cardiac surgery, N Engl J Med, 372, 997, 10.1056/NEJMoa1403612
Hajjar, 2010, Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial, JAMA, 304, 1559, 10.1001/jama.2010.1446
von Heymann, 2006, The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome–a randomized controlled study [ISRCTN35655335], Crit Care, 10, R58, 10.1186/cc4891
Klausen, 2014, Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients, Transfus Apher Sci, 51, 97, 10.1016/j.transci.2014.08.007
Dwyre, 2011, Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century, Vox Sang, 100, 92, 10.1111/j.1423-0410.2010.01426.x
Shaz, 2011, Transfusion-related acute lung injury: from bedside to bench and back, Blood, 117, 1463, 10.1182/blood-2010-04-278135
Dunbar, 2015, Current options for transfusion-related acute lung injury risk mitigation in platelet transfusions, Curr Opin Hematol, 22, 554, 10.1097/MOH.0000000000000187
Vamvakas, 2007, Transfusion-related immunomodulation (TRIM): an update, Blood Rev, 21, 327, 10.1016/j.blre.2007.07.003
Blumberg, 2007, The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients, Transfusion, 47, 573, 10.1111/j.1537-2995.2007.01158.x
Rohde, 2014, Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis, JAMA, 311, 1317, 10.1001/jama.2014.2726
Bilgin, 2004, Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery, Circulation, 109, 2755, 10.1161/01.CIR.0000130162.11925.21
Sartipy, 2015, Red blood cell concentrate storage and survival after cardiac surgery, JAMA, 314, 1641, 10.1001/jama.2015.8690
Alexander, 2016, Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis, Blood, 127, 400, 10.1182/blood-2015-09-670950
Vamvakas, 2009, Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks, Transfusion, 49, 2743, 10.1111/j.1537-2995.2009.02338.x
Welsby, 2010, Storage age of transfused platelets and outcomes after cardiac surgery, Transfusion, 50, 2311, 10.1111/j.1537-2995.2010.02747.x
Ogawa, 2012, The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry, Anesth Analg, 115, 16, 10.1213/ANE.0b013e31824d523b
Wikkelso, 2016, Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding, Cochrane Database Syst Rev, 8
Whiting, 2015, Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and costeffectiveness analysis, Health Technol Assess, 19, 1, 10.3310/hta19580
Weber, 2012, Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients, Anesthesiology, 117, 531, 10.1097/ALN.0b013e318264c644
Song, 2014, Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations, Ann Thorac Surg, 97, 1630, 10.1016/j.athoracsur.2013.12.025
Ranucci, 2015, Acute kidney injury and hemodilution during cardiopulmonary bypass: a changing scenario, Ann Thorac Surg, 100, 95, 10.1016/j.athoracsur.2015.02.034
Patel, 2015, Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis, Lancet Haematol, 2, e543, 10.1016/S2352-3026(15)00198-2
Nakamura, 2015, A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery, J Thorac Cardiovasc Surg, 150, 1314, 10.1016/j.jtcvs.2015.07.051
Kumar, 2015, Platelet transfusion: a systematic review of the clinical evidence, Transfusion, 55, 1116, 10.1111/trf.12943
Kaufman, 2015, Platelet transfusion: a clinical practice guideline from the AABB, Ann Intern Med, 162, 205, 10.7326/M14-1589
Annich, 2015, Extracorporeal life support: the precarious balance of hemostasis, J Thromb Haemost, 13, S336, 10.1111/jth.12963
Wool, 2013, Pathology consultation on anticoagulation monitoring: factor X-related assays, Am J Clin Pathol, 140, 623, 10.1309/AJCPR3JTOK7NKDBJ
Price, 2013, Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin, Ann Pharmacother, 47, 151, 10.1345/aph.1R635
Adatya, 2015, Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support, JACC Heart Fail, 3, 314, 10.1016/j.jchf.2014.11.009
Koster, 2003, An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study, Anesth Analg, 96, 1316, 10.1213/01.ANE.0000057605.61063.55
Hoechter, 2015, The munich lung transplant group: intraoperative extracorporeal circulation in lung transplantation, Thorac Cardiovasc Surg, 63, 706, 10.1055/s-0035-1556873
Bembea, 2013, Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey, Pediatr Crit Care Med, 14, e77, 10.1097/PCC.0b013e31827127e4
Chu, 2015, Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation, Intensive Care Med, 41, 369, 10.1007/s00134-014-3574-3
Yeo, 2015, Low-dose heparin during extracorporeal membrane oxygenation treatment in adults, Intensive Care Med, 41, 2020, 10.1007/s00134-015-4015-7
Byrnes, 2014, Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life, ASAIO J, 60, 57, 10.1097/MAT.0000000000000010
Ranucci, 2016, Coagulation monitoring in postcardiotomy ECMO: conventional tests, point-of-care, or both?, Minerva Anestesiol, 82, 858
Ranucci, 2011, Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation, Crit Care, 15, R275, 10.1186/cc10556
Pieri, 2013, Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study, J Cardiothorac Vasc Anesth, 27, 30, 10.1053/j.jvca.2012.07.019